Phase III Trial of Citicoline 2000 mg vs Placebo "Citicoline ECCO 2000"

Completed

Phase 3 Results

Summary of Purpose

To compare the neurological function of citicoline (CerAxon) treated patients with that of placebo patients at 12 weeks following stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 July 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Interneuron Pharmaceuticals, Lexington, MA

Trial Design

Multi-center, randomized, double-blind, palceb0-controlled efficacy trial of 899 patients.

Contacts

Not available